Aristeia Capital’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Aristeia Capital’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-449,998	Closed	-$4.55M	–	581
2022 Q3	$4.55M	Hold	449,998	–	–	0.08%	301
2022 Q2	$4.52M	Buy	449,998 +100,000	+29%	+$1M	0.08%	284
2022 Q1	$3.5M	Buy	+349,998	New	+$3.5M	0.06%	308

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Aristeia Capital's ARCK Position: Q4 2022 in Review

Aristeia Capital sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 449,998 shares — an estimated $4.55M sold.

Aristeia Capital first reported a position in ARCK in Q1 2022 and held it in 3 quarters. The position peaked at $4.55M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Aristeia Capital reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Aristeia Capital sold 449,998 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $4.55M.
Aristeia Capital first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q1 2022 and held it in 3 quarters.
Aristeia Capital's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $4.55M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Aristeia Capital's 13F filing for Q4 2022, filed 14 Feb 2023.